Who owns the LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.) trademark?

The LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.) trademark is owned by Nexzol Pharma, Inc..

What class is the LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.) trademark registered in?

The LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)?

The USPTO serial number for LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.) is 88281416.

What is the registration number for LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)?

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.) is registered under USPTO registration number 0.

LOC

USPTO Trademark Record

ABANDONED

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

SN 88281416·Reg 0·Filed Jan 29, 2019

Owner Nexzol Pharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.) (Serial No. 88281416), Registration No. 0, is a abandoned US trademark filed on Jan 29, 2019 by Nexzol Pharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.) (Reg. #0) is an abandoned US trademark that was filed in 2019 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 29, 2019

SERIAL

88281416

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Nexzol Pharma, Inc.

Entity

Corporation

State

Address

1001 Avenida Pico, Suite C-501, San Clemente, CA, 92673

Country

Attorney

NameSean MacKenzie

Law firm

SEAN MACKENZIE

Address

501 N. EL CAMINO REAL, SUITE 200, SAN CLEMENTE, CA 92672, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJan 29, 2019

Serial Number88281416

Registration No.0

Registration DateDec 31, 1969

Status DateNov 22, 2020

Published for OppositionJun 11, 2019

Mark TypeStandard characters

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Aug 01, 2019

First use in commerce: Aug 01, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Nov 23, 2020

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Nov 22, 2020

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

SU - NON-FINAL ACTION - WRITTEN

May 06, 2020

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

May 06, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 06, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 01, 2020

ASSIGNED TO EXAMINER

Dec 30, 2019

ASSIGNED TO EXAMINER

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 20, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Dec 20, 2019

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Dec 12, 2019

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Dec 12, 2019

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 06, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 11, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 11, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 22, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

May 03, 2019

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

May 01, 2019

ASSIGNED TO LIE

EXAMINERS AMENDMENT -WRITTEN

Apr 18, 2019

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 18, 2019

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 18, 2019

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 18, 2019

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 18, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Apr 10, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 21, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 01, 2019

NEW APPLICATION ENTERED

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Nexzol Pharma, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Sean MacKenzie

Resources

Company